The Hepatitis C Virus Protein NS3 Suppresses TNF-α–stimulated Activation of NF-κB by Targeting LUBAC
Yongzhi Chen,Liang He,Yanan Peng,Xiaodong Shi,Jizheng Chen,Jin Zhong,Xinwen Chen,Genhong Cheng,Hongyu Deng
DOI: https://doi.org/10.1126/scisignal.aab2159
IF: 9.517
2015-01-01
Science Signaling
Abstract:The transcription factor nuclear factor kB (NF-kappa B) is crucial for innate immune defense against viral infections, and its activation requires the ubiquitylation of upstream proteins, including the adaptor protein NEMO (NF-kappa B essential modulator). Many infectious pathogens, including hepatitis C virus (HCV), inhibit NF-kappa B signaling in host cells, which promotes pathogen survival. Frequently, HCV-infected individuals develop a chronic infection, which suggests that HCV can subvert host antiviral responses. We found that HCV infection and replication inhibited the activation of NF-kappa B by the inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha), which was mediated by the viral protein NS3 and, to a lesser extent, NS5B. NS3 directly interacted with linear ubiquitin chain assembly complex (LUBAC), competed with NEMO for binding to LUBAC, and inhibited the LUBAC-mediated linear ubiquitylation of NEMO and the subsequent activation of NF-kappa B. Together, our results highlight an immune evasion strategy adopted by HCV to modulate host antiviral responses and enhance virus survival and persistence.
What problem does this paper attempt to address?